Allurion Technologies (ALURD) Income from Continuing Operations (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Income from Continuing Operations came in at 6095000.0 in Q1 2026, down 306.06% YoY from 2957838.67 in Q1 2025, and up 2.96% on a QoQ basis from 6281000.0 in Q4 2025.
Allurion Technologies (ALURD) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Income from Continuing Operations data on file, last reported at 6095000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 306.06% year-over-year to 6095000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33595000.0 (down 206.61% YoY) and the FY2025 annual result came in at 28954000.0, down 291.59% from the prior year.
- Income from Continuing Operations grew to 6095000.0 in Q1 2026, from 6281000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 8705000.0 in Q3 2024 to a low of 21996000.0 in Q2 2023.
- A 5-year average of 9836750.0 and a median of 9569500.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 306.96% — and 2024, when it jumped 140.25%.
- Tracing ALURD's Income from Continuing Operations over 5 years: stood at 13014000.0 in 2022, then tumbled by 64.36% to 21390000.0 in 2023, then surged by 54.17% to 9804000.0 in 2024, then surged by 35.93% to 6281000.0 in 2025, then gained by 2.96% to 6095000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 6095000.0 (Q1 2026), 6281000.0 (Q4 2025), and 11884000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -9.80 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | -13.01 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |